Erika I Melchy-Pérez (Erika Melchy-Pérez)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Escherichia Coli

Anti Inflammatory Drugs

Top Venues

International journal of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Claire Lacombe, Estefania Aleman-Navaro, Thierry Drujon, Veronica Martinez-Osorio, Emmanuelle Sachon, Erika I Melchy-Pérez, Ludovic Carlier, Lorena Elizabeth Fajardo Brigido, Yannick Fleury, Christophe Piesse, Guadalupe Gutiérrez-Escobedo, Alejandro De Las Peñas, Irene Castaño, Florie Desriac, José Luis Beristain-Hernández, Christophe Combadière, Yvonne Rosenstein, Constance Auvynet
Characterization of a New Immunosuppressive and Antimicrobial Peptide, DRS-DA2, Isolated from the Mexican Frog, Pachymedusa dacnicolor . International journal of inflammation 2024 (2024)
Claire Lacombe, Estefania Aleman-Navaro, Thierry Drujon, Veronica Martinez-Osorio, Emmanuelle Sachon, Erika I Melchy-Pérez, Ludovic Carlier, Lorena Elizabeth Fajardo Brigido, Yannick Fleury, Christophe Piesse, Guadalupe Gutiérrez-Escobedo, Alejandro De Las Peñas, Irene Castaño, Florie Desriac, José Luis Beristain-Hernández, Christophe Combadière, Yvonne Rosenstein, Constance Auvynet
Characterization of a New Immunosuppressive and Antimicrobial Peptide, DRS-DA2, Isolated from the Mexican Frog, Pachymedusa dacnicolor . International journal of inflammation 2024 (2024)
Deyanira Pérez-Morales, Jessica Nava-Galeana, Roberto Rosales-Reyes, Paige Teehan, Helen Yakhnin, Erika I Melchy-Pérez, Yvonne Rosenstein, Miguel A De La Cruz, Paul Babitzke, Deyanira Pérez-Morales
An incoherent feedforward loop formed by SirA/BarA, HilE and HilD is involved in controlling the growth cost of virulence factor expression by Salmonella Typhimurium. PLoS pathogens 17 (5) (2021)